UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 98

Sortiert nach

The Evolving Role of Fetuin-A in Nonalcoholic Fatty Liver Disease: An Overview from Liver to the Heart

International journal of molecular sciences, 2021-06, Vol.22 (12), p.6627

2021

Volltextzugriff (PDF)

The relationship of atherogenic index of plasma with endothelial dysfunction biomarkers in patients with metabolic associated fatty liver disease

Gülhane tıp dergisi, 2022-09, Vol.64 (3), p.240-247

2022

Volltextzugriff (PDF)

Association of plasma visfatin with hepatic and systemic inflammation in nonalcoholic fatty liver disease

Annals of hepatology, 2013-07, Vol.12 (4), p.548-387

2013

Volltextzugriff (PDF)

Low- and high-density lipoprotein subclasses in subjects with nonalcoholic fatty liver disease

Journal of clinical lipidology, 2015-07, Vol.9 (4), p.576-582

2015

Volltextzugriff (PDF)

Betatrophin Levels Are Related to the Early Histological Findings in Nonalcoholic Fatty Liver Disease

Metabolites, 2021-06, Vol.11 (7), p.425

2021

Volltextzugriff (PDF)

Elevated asymmetric dimethylarginine in plasma: An early marker for endothelial dysfunction in non-alcoholic fatty liver disease?

Diabetes research and clinical practice, 2012-04, Vol.96 (1), p.47-52

2012

Volltextzugriff (PDF)

The relationship of circulating fetuin-a with liver histology and biomarkers of systemic inflammation in nondiabetic subjects with nonalcoholic fatty liver disease

Saudi journal of gastroenterology, 2015-05, Vol.21 (3), p.139-145

2015

Volltextzugriff (PDF)

Gilbert’s syndrome: protective effect on endothelial dysfunction

Turkish Journal of Biochemistry, 2016-12, Vol.41 (6), p.451-458

2016

Volltextzugriff (PDF)

Letter: metformin treatment and hepatocellular carcinoma risk in non‐alcoholic fatty liver disease

Alimentary pharmacology & therapeutics, 2019-10, Vol.50 (7), p.835-836

2019

Volltextzugriff (PDF)

The relationship between blood urea nitrogen levels and metabolic, biochemical, and histopathologic findings of nondiabetic, nonhypertensive patients with nonalcoholic fatty liver disease

Turkish journal of medical sciences, 2016-06, Vol.46 (4), p.985-991

2016

Volltextzugriff (PDF)

Betatrophin in nonalcoholic fatty liver disease

European journal of gastroenterology & hepatology, 2016-04, Vol.28 (4), p.487-488

2016

Volltextzugriff (PDF)

Chitotriosidase activity predicts endothelial dysfunction in type-2 diabetes mellitus

Endocrine, 2010-06, Vol.37 (3), p.455-459

2010

Volltextzugriff (PDF)

Visfatin and gallstone disease

The American journal of surgery, 2012-03, Vol.203 (3), p.410-410

2012

Volltextzugriff (PDF)

Effect of a hypocaloric diet on serum visfatin in obese non-diabetic patients

Nutrition (Burbank, Los Angeles County, Calif.), 2009-02, Vol.25 (2), p.240-240

2009

Volltextzugriff (PDF)

The effect of fluvastatin on plasma adiponectin levels in dyslipidaemia

Clinical endocrinology (Oxford), 2006-05, Vol.64 (5), p.567-572

2006

Volltextzugriff (PDF)

The relationship of serum uric acid with non-alcoholic fatty liver disease

Clinical biochemistry, 2014-04, Vol.47 (6), p.383-388

2014

Volltextzugriff (PDF)

Plasma fetuin-A is associated with endothelial dysfunction and subclinical atherosclerosis in subjects with nonalcoholic fatty liver disease

Clinical endocrinology (Oxford), 2013-05, Vol.78 (5), p.712-717

2013

Volltextzugriff (PDF)

Carotid atherosclerosis or nonalcoholic fatty liver disease: Which comes first?

Atherosclerosis, 2013-12, Vol.231 (2), p.187-188

2013

Volltextzugriff (PDF)

Adiponectin and Insulin Resistance in Young and Healthy Smokers

Endocrine Journal, 2006, Vol.53(6), pp.729-734

2006

Volltextzugriff (PDF)

Serum adipokine levels in the obese people

International journal of biological sciences, 2009-01, Vol.5 (3), p.286-286

2009

Volltextzugriff (PDF)

Uric acid in nonalcoholic fatty liver disease

European journal of gastroenterology & hepatology, 2016-05, Vol.28 (5), p.609-610

2016

Volltextzugriff (PDF)

Plasma visfatin levels in patients with newly diagnosed and untreated type 2 diabetes mellitus and impaired glucose tolerance

Diabetes research and clinical practice, 2007-04, Vol.76 (1), p.24-29

2007

Volltextzugriff (PDF)

C reactive protein levels in non-alcoholic fatty liver disease

Journal of hepatology, 2012-02, Vol.56 (2), p.507-508

2012

Volltextzugriff (PDF)

Comment on Dalmas et al. Intima-media thickness in severe obesity: links with BMI and metabolic status but not with systemic or adipose tissue inflammation. Diabetes care 2013;36:3793-3802

Diabetes care, 2014-05, Vol.37 (5), p.e118-e118

2014

Volltextzugriff (PDF)

Neutrophil-to-lymphocyte ratio as a predictor of fibrosis in inactive hepatitis B carriers

European journal of gastroenterology & hepatology, 2015-04, Vol.27 (4), p.475-476

2015

Volltextzugriff (PDF)

1 – 25 von 98

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(88)
Mit Volltextzugriff
(96)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The Evolving Role of Fetuin-A in Nonalcoholic Fatty Liver Disease: An Overview from Liver to the Heart

The relationship of atherogenic index of plasma with endothelial dysfunction biomarkers in patients with metabolic associated fatty liver disease

Association of plasma visfatin with hepatic and systemic inflammation in nonalcoholic fatty liver disease

Low- and high-density lipoprotein subclasses in subjects with nonalcoholic fatty liver disease

Betatrophin Levels Are Related to the Early Histological Findings in Nonalcoholic Fatty Liver Disease

Elevated asymmetric dimethylarginine in plasma: An early marker for endothelial dysfunction in non-alcoholic fatty liver disease?

The relationship of circulating fetuin-a with liver histology and biomarkers of systemic inflammation in nondiabetic subjects with nonalcoholic fatty liver disease

Gilbert’s syndrome: protective effect on endothelial dysfunction

Letter: metformin treatment and hepatocellular carcinoma risk in non‐alcoholic fatty liver disease

The relationship between blood urea nitrogen levels and metabolic, biochemical, and histopathologic findings of nondiabetic, nonhypertensive patients with nonalcoholic fatty liver disease

Betatrophin in nonalcoholic fatty liver disease

Chitotriosidase activity predicts endothelial dysfunction in type-2 diabetes mellitus

Visfatin and gallstone disease

Effect of a hypocaloric diet on serum visfatin in obese non-diabetic patients

The effect of fluvastatin on plasma adiponectin levels in dyslipidaemia

The relationship of serum uric acid with non-alcoholic fatty liver disease

Plasma fetuin-A is associated with endothelial dysfunction and subclinical atherosclerosis in subjects with nonalcoholic fatty liver disease

Carotid atherosclerosis or nonalcoholic fatty liver disease: Which comes first?

Adiponectin and Insulin Resistance in Young and Healthy Smokers

Serum adipokine levels in the obese people

Uric acid in nonalcoholic fatty liver disease

Plasma visfatin levels in patients with newly diagnosed and untreated type 2 diabetes mellitus and impaired glucose tolerance

C reactive protein levels in non-alcoholic fatty liver disease

Comment on Dalmas et al. Intima-media thickness in severe obesity: links with BMI and metabolic status but not with systemic or adipose tissue inflammation. Diabetes care 2013;36:3793-3802

Neutrophil-to-lymphocyte ratio as a predictor of fibrosis in inactive hepatitis B carriers

Suchergebnisse filtern